Using the CellSeach platform, FISH, and flow cytometry in conjunction with the M30 antibody which recognizes caspase cleaved CK18, several groups have shown that a significant number of CTCs isolated from metastatic prostate cancer patients are apoptotic [34], [36]–[38]. Here, KRT18 is linked to metastatic prostate carcinoma.